Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Cell. 2023 Oct 26;186(22):4920-4935.e23. doi: 10.1016/j.cell.2023.08.031. Epub 2023 Sep 29.
SpCas9 and AsCas12a are widely utilized as genome-editing tools in human cells. However, their relatively large size poses a limitation for delivery by cargo-size-limited adeno-associated virus (AAV) vectors. The type V-F Cas12f from Acidibacillus sulfuroxidans is exceptionally compact (422 amino acids) and has been harnessed as a compact genome-editing tool. Here, we developed an approach, combining deep mutational scanning and structure-informed design, to successfully generate two AsCas12f activity-enhanced (enAsCas12f) variants. Remarkably, the enAsCas12f variants exhibited genome-editing activities in human cells comparable with those of SpCas9 and AsCas12a. The cryoelectron microscopy (cryo-EM) structures revealed that the mutations stabilize the dimer formation and reinforce interactions with nucleic acids to enhance their DNA cleavage activities. Moreover, enAsCas12f packaged with partner genes in an all-in-one AAV vector exhibited efficient knock-in/knock-out activities and transcriptional activation in mice. Taken together, enAsCas12f variants could offer a minimal genome-editing platform for in vivo gene therapy.
SpCas9 和 AsCas12a 被广泛用作人类细胞中的基因组编辑工具。然而,它们相对较大的尺寸限制了其通过货物大小限制的腺相关病毒 (AAV) 载体进行递送。来自硫氧化酸杆菌的 V-F Cas12f 是一种非常紧凑的(422 个氨基酸),并被用作一种紧凑的基因组编辑工具。在这里,我们开发了一种结合深度突变扫描和结构信息设计的方法,成功生成了两种增强型 AsCas12f 活性(enAsCas12f)变体。值得注意的是,enAsCas12f 变体在人类细胞中的基因组编辑活性可与 SpCas9 和 AsCas12a 相媲美。低温电子显微镜 (cryo-EM) 结构表明,突变稳定了二聚体的形成并增强了与核酸的相互作用,从而增强了它们的 DNA 切割活性。此外,在一个一体式 AAV 载体中包装有伴侣基因的 enAsCas12f 在小鼠中表现出高效的基因敲入/敲除活性和转录激活。总之,enAsCas12f 变体可以为体内基因治疗提供一个最小的基因组编辑平台。